Literature DB >> 11313246

Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells.

R Guerriero1, G Mattia, U Testa, C Chelucci, G Macioce, I Casella, P Samoggia, C Peschle, H J Hassan.   

Abstract

The alpha chemokine receptor CXCR4 has been shown to be expressed on human hematopoietic progenitor cells and during the megakaryocytic differentiation pathway. Stromal cell-derived factor 1 (SDF-1) is the ligand for CXCR4. In this study, the role of SDF-1alpha in megakaryocytopoiesis was investigated. CD34(+) progenitors purified from peripheral blood were grown in serum-free liquid suspension culture supplemented with thrombopoietin to obtain a virtually pure megakaryocytic progeny. In this condition, the addition of SDF-1alpha gives rise to megakaryocytes (MKs) showing an increased DNA content and a rise of lobated nuclei, as compared with untreated cells: at day 5, approximately 20% of the cells already showed the presence of more than one nuclear lobe versus fewer than 5% in the control cells; at day 12, approximately 85% of the cells were of large size and markedly polyploid, whereas approximately 60% of the control cells were polyploid, showed fewer lobes, and were a smaller size. This effect was dose-dependent and did not affect the megakaryocytic proliferation. Experiments with the mitogen-activated protein kinase (MAPK) inhibitor PD98059 suggested a role for MAPK pathway on SDF-1alpha-induced endomitosis. Furthermore, SDF-1alpha induced a significant increase in the number of proplatelet-bearing MKs and promoted the migration of megakaryocytic cells. Treatment with SDF-1alpha caused reduction in CXCR4 abundance on the plasma membrane, seemingly owing to receptor internalization. Furthermore, the presence of SDF-1alpha did not affect the expression of megakaryocytic markers, indicating that differentiation and polyploidization are independently regulated events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313246     DOI: 10.1182/blood.v97.9.2587

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein.

Authors:  D Gibellini; M C Re; F Vitone; N Rizzo; C Maldini; M La Placa; G Zauli
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

Review 2.  Megakaryocyte ontogeny: Clinical and molecular significance.

Authors:  Kamaleldin E Elagib; Ashton T Brock; Adam N Goldfarb
Journal:  Exp Hematol       Date:  2018-03-02       Impact factor: 3.084

3.  Conditional CRISPR-mediated deletion of Lyn kinase enhances differentiation and function of iPSC-derived megakaryocytes.

Authors:  Alyssa J Moroi; Peter J Newman
Journal:  J Thromb Haemost       Date:  2021-10-17       Impact factor: 5.824

4.  Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition.

Authors:  Lisa M Giammona; Swapna Panuganti; Jan M Kemper; Pani A Apostolidis; Stephan Lindsey; Eleftherios T Papoutsakis; William M Miller
Journal:  Exp Hematol       Date:  2009-08-26       Impact factor: 3.084

5.  SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury.

Authors:  Lisa M Niswander; Katherine H Fegan; Paul D Kingsley; Kathleen E McGrath; James Palis
Journal:  Blood       Date:  2014-04-15       Impact factor: 22.113

6.  MiR-9 contributes to the developmental differences in CXCR-4 expression in human megakaryocytes.

Authors:  F Ferrer-Marin; R Gutti; Z-J Liu; M Sola-Visner
Journal:  J Thromb Haemost       Date:  2014-02       Impact factor: 5.824

7.  HB-EGF directs stromal cell polyploidy and decidualization via cyclin D3 during implantation.

Authors:  Yi Tan; Meiling Li; Sandra Cox; Marilyn K Davis; Ossama Tawfik; Bibhash C Paria; Sanjoy K Das
Journal:  Dev Biol       Date:  2004-01-01       Impact factor: 3.582

8.  MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation.

Authors:  W Zhao; H He; K Ren; B Li; H Zhang; Y Lin; R-G Shao
Journal:  Blood Cancer J       Date:  2013-03-29       Impact factor: 11.037

9.  Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.

Authors:  Alexandra Mazharian; Steve P Watson; Sonia Séverin
Journal:  Exp Hematol       Date:  2009-07-18       Impact factor: 3.084

10.  The High Yield Expansion and Megakaryocytic Differentiation of Human Umbilical Cord Blood CD133(+) Cells.

Authors:  Mahin Nikougoftar Zarif; Masoud Soleimani; Hassan Abolghasemi; Naser Amirizade; Saeid Abroun; Saeid Kaviani
Journal:  Cell J       Date:  2011-09-23       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.